Trial Profile
The effect of Acomplia (rimonabant) on esophageal sensitivity and gastric accommodation during food intake in healthy volunteers: a single-blind, placebo-controlled study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2021
Price :
$35
*
At a glance
- Drugs Rimonabant (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 05 Mar 2021 Status changed from recruiting to completed.
- 20 Aug 2014 New trial record